PharmaFluidics, a Belgium-based research diagnostics spinout from Vrije Universiteit Brussel (VUB), secured €7.3m ($9m) on Thursday in a round featuring multi-university venturing firm Qbic.

The round included Theodorus, the investment fund of Université libre de Bruxelles, as well as Flemish government-owned investment arm Participatiemaatschappij Vlaanderen (PMV) and family offices Heran and RMM.

Impact investment firm Volksvermogen and life sciences-focused VC vehicle Innovation Fund were also named as participants. Qbic focuses on spinouts from VUB, University of Antwerp and technological research…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?